Bulenox vs Topstep
An objective, side-by-side look at Bulenox and Topstep — where each tends to be stronger.
Bulenox and Topstep both fund futures traders, but they come from different places: Bulenox emphasises flexible funding routes, while Topstep is one of the longest-established names with a strong education focus.
At a glance
| Category | Bulenox | Topstep |
|---|---|---|
| Account model | Qualification, Fast Track, Momentum → Master | Trading Combine → funded account |
| Evaluation | Multiple routes; no min days to pass | Combine with profit target and rules |
| Drawdown | Choice of trailing or end-of-day | Trailing drawdown |
| Payouts | 100% of first $10k, then split | Published profit split and payout policy |
| Platforms | 20+ supported | Own platform plus supported options |
| Best suited for | Flexible routes and risk-model choice | Reputation, education and structure |
What they have in common
Both are evaluation-based futures firms with profit targets, drawdown rules, and funded accounts that can request payouts. Both publish their rules openly and support popular ways to trade.
Key differences
Topstep’s strengths are its longevity, reputation and education around the Trading Combine. Bulenox’s strengths are flexibility — multiple funding routes and a choice of drawdown model — and keeping 100% of the first $10,000. Topstep’s structure is more standardised; Bulenox offers more up-front choices, with the trade-off that its drawdown model is locked.
Which should you choose?
Bulenox may be better for traders who want to tailor their funding route and risk model and value an early full-profit tier. Topstep may be better for traders who prioritise a long track record, structured education, and a well-known process. Verify current terms on both sites.
Related guides
Explore Bulenox
Understand the accounts and rules, then decide.
Bulenox Traders provides educational and informational content and does not provide financial or investment advice. We may earn a commission if you use links on this site. Affiliate disclosure.